Daphne de Jong

25.0k total citations · 1 hit paper
214 papers, 10.3k citations indexed

About

Daphne de Jong is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Daphne de Jong has authored 214 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Pathology and Forensic Medicine, 90 papers in Oncology and 47 papers in Genetics. Recurrent topics in Daphne de Jong's work include Lymphoma Diagnosis and Treatment (122 papers), Viral-associated cancers and disorders (45 papers) and Chronic Lymphocytic Leukemia Research (43 papers). Daphne de Jong is often cited by papers focused on Lymphoma Diagnosis and Treatment (122 papers), Viral-associated cancers and disorders (45 papers) and Chronic Lymphocytic Leukemia Research (43 papers). Daphne de Jong collaborates with scholars based in Netherlands, United States and Germany. Daphne de Jong's co-authors include Ed Schuuring, Henk Boot, J. Han van Krieken, P.M. Kluin, Jacqueline Limpens, Yasodha Natkunam, Jan Paul de Boer, Philip M. Kluin, Rick L. Haas and Michael Hauptmann and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Biological Chemistry.

In The Last Decade

Daphne de Jong

209 papers receiving 10.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome

2016 555 citations Margaretha G.M. Roemer, Ranjana H. Advani et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Daphne de Jong

Since Specialization

Citations

This map shows the geographic impact of Daphne de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daphne de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daphne de Jong more than expected).

Fields of papers citing papers by Daphne de Jong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daphne de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daphne de Jong. The network helps show where Daphne de Jong may publish in the future.

Co-authorship network of co-authors of Daphne de Jong

This figure shows the co-authorship network connecting the top 25 collaborators of Daphne de Jong. A scholar is included among the top collaborators of Daphne de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daphne de Jong. Daphne de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	BRCA1/2 impact on the development of implant-associated lymphoma in women with breast cancer and textured implants 2025 ·Blood Advances ·Paola Ghione, Diana Mandelker, Maria E. Arcila, Venkatraman Seshan, (unknown), Joseph Vijai, (unknown), Chad Vanderbilt, Joyce C. Pressley, Alexander Chan, Natasha Galasso, Ahmet Doǧan, Gilles Salles, Daphne de Jong, Flora E. van Leeuwen, Sarah McCue Horwitz	0
2	Antigen-independent, autonomous B cell receptor signaling drives activated B cell DLBCL 2024 ·The Journal of Experimental Medicine ·(unknown), Marvyn T. Koning, (unknown), (unknown), Ruben A. L. de Groen, Edwin Quinten, (unknown), Cornelis A.M. van Bergen, Joost S.P. Vermaat, Arjen H.G. Cleven, Marcelo A. Navarrete, Bauke Ylstra, Daphne de Jong, Ondřej Havránek, Hassan Jumaa, Hendrik Veelken	5
3	Personalised therapy in follicular lymphoma – is the dial turning? 2023 ·Hematological Oncology ·Kim Linton, Lena Specht, Astrid Pavlovsky, Carrie A. Thompson, Eva Kimby, Daphne de Jong, Loretta J. Nastoupil, Anne‐Ségolène Cottereau, Carla Casulo, Clémentine Sarkozy, Jessica Okosun	4
4	The spectrum of nodular lymphocyte predominant Hodgkin lymphoma: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology 2023 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Sylvia Hartmann, Stefan Dojcinov, Snježana Dotlić, Sarah E. Gibson, Eric D. Hsi, Wolfram Klapper, Monika Klimkowska, Socorro Marıá Rodríguez-Pinilla, Julia Richter, Elena Sabattini, Thomas Tousseyn, Daphne de Jong	4
5	Large B-cell Lymphomas of Immune-Privileged Sites Relapse via Parallel Clonal Evolution from a Common Progenitor B Cell 2023 ·Cancer Research ·G. Tjitske Los-de Vries, (unknown), (unknown), Nathalie J. Hijmering, (unknown), Patricia J.T.A. Groenen, Daphne de Jong, Bauke Ylstra, Margaretha G.M. Roemer	10
6	Lymphomas with plasmablastic features: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology 2023 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Snježana Dotlić, Sarah E. Gibson, Sylvia Hartmann, Eric D. Hsi, Monika Klimkowska, Socorro Marıá Rodríguez-Pinilla, Elena Sabattini, Thomas Tousseyn, Daphne de Jong, Stefan Dojcinov	1
7	Aggressive B-cell non-Hodgkin lymphomas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology 2023 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Socorro Marıá Rodríguez-Pinilla, Stefan Dojcinov, Snježana Dotlić, Sarah E. Gibson, Sylvia Hartmann, Monika Klimkowska, Elena Sabattini, Thomas Tousseyn, Daphne de Jong, Eric D. Hsi	3
8	Mediastinal large B cell lymphoma and surrounding gray areas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology 2023 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Sarah E. Gibson, Stefan Dojcinov, Snježana Dotlić, Sylvia Hartmann, Eric D. Hsi, Monika Klimkowska, (unknown), Stefano Pileri, (unknown), Karen L. Rech, Lisa M. Rimsza, Socorro Marıá Rodríguez-Pinilla, Thomas Tousseyn, Daphne de Jong, Elena Sabattini	5
9	Career development: A balance of opportunities and choices 2023 ·Hematological Oncology ·Daphne de Jong, Eva Kimby, Lena Specht	2
10	Survival, neurocognitive function, and health-related quality of life outcomes after rituximab—methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study 2023 ·Neuro-Oncology ·Jacoline E. C. Bromberg, Samar Issa, Bronno van der Holt, Matthijs van der Meulen, Linda Dirven, Monique C. Minnema, Tatjana Seute, Marc Durian, Gavin Cull, Marjolein van der Poel, Wendy B.C. Stevens, Josée M. Zijlstra, Dieta Brandsma, Marcel Nijland, Kylie D. Mason, Aart Beeker, (unknown), Martin J. van den Bent, Daphne de Jong, Jeanette K. Doorduijn	5
11	Reproducibility of Gene Expression Signatures in Diffuse Large B-Cell Lymphoma 2022 ·Cancers ·Jéssica Rodrigues Plaça, Arjan Diepstra, G. Tjitske Los-de Vries, (unknown), (unknown), Pieternella J. Lugtenburg, Josée M. Zijlstra, King H. Lam, Wilson A. Silva, Bauke Ylstra, Daphne de Jong, Anke van den Berg, Marcel Nijland	1
12	Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage: a nationwide, population-based study in the Netherlands, 1989–2018 2022 ·Blood Cancer Journal ·(unknown), Otto Visser, Eduardus F. M. Posthuma, Rolf E. Brouwer, Djamila E. Issa, Daphne de Jong, King H. Lam, Nicole M. A. Blijlevens, Josée M. Zijlstra, Martine E.D. Chamuleau, Pieternella J. Lugtenburg, Marie José Kersten, Avinash G. Dinmohamed	11
13	Chromosome 20 loss is characteristic of breast implant–associated anaplastic large cell lymphoma 2020 ·Blood ·G. Tjitske Los-de Vries, Mintsje de Boer, Erik van Dijk, (unknown), Nathalie J. Hijmering, Margaretha G.M. Roemer, (unknown), Daniël M. Miedema, Jan Paul de Boer, Hinne A. Rakhorst, Flora E. van Leeuwen, René R. W. J. van der Hulst, Bauke Ylstra, Daphne de Jong	35
14	Increased prevalence of BRCA1/2 mutations in women with macrotextured breast implants and anaplastic large cell lymphoma of the breast 2020 ·Blood ·Mintsje de Boer, Michael Hauptmann, Nathalie J. Hijmering, Carel J.M. van Noesel, Hinne A. Rakhorst, Hanne Meijers‐Heijboer, Jan Paul de Boer, René R. W. J. van der Hulst, Daphne de Jong, Flora E. van Leeuwen	25
15	First Report on a Successful Screening Program for MYC Rearrangements and a Prospective Clinical Trial Based on MYC Rearrangement in Newly Diagnosed DLBCL Patients in the Netherlands 2017 ·Blood ·Martine E.D. Chamuleau, Marcel Nijland, (unknown), Nathalie J. Hijmering, Dana Chiţu, Josée M. Zijlstra, Otto Visser, Josephine M. I. Vos, Henriette W Berenschot, Rinske Boersma, Marie José Kersten, Daphne de Jong	0
16	Classical Hodgkin Lymphoma with Reduced β2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status 2016 ·Cancer Immunology Research ·Margaretha G.M. Roemer, Ranjana H. Advani, Robert Redd, Geraldine S. Pinkus, Yasodha Natkunam, Azra H. Ligon, Courtney Connelly, Christine J. Pak, Christopher D. Carey, Sarah E. Daadi, Bjoern Chapuy, Daphne de Jong, Richard T. Hoppe, Donna Neuberg, Margaret A. Shipp, Scott J. Rodig	139
17	Diffuse large B-cell lymphoma with MYC gene rearrangements 2016 ·European Journal of Cancer ·(unknown), (unknown), Ilse Houtenbos, (unknown), (unknown), Jan Paul de Boer, (unknown), (unknown), Aart Beeker, G.J. Timmers, C. G. Schaar, Marcel Soesan, Pino J. Poddighe, Daphne de Jong, Martine E.D. Chamuleau	15
18	Gene-Expression and Immunohistochemical Study of Specific T-Cell Subsets and Accessory Cell Types in the Transformation and Prognosis of Follicular Lymphoma 2007 ·Journal of Clinical Oncology ·Annuska M. Glas, Laurent Knoops, Leonie Delahaye, Marie José Kersten, Robby E. Kibbelaar, (unknown), Ryan K. van Laar, J. Han van Krieken, Joke W. Baars, John Raemaekers, Philip M. Kluin, Laura van ‘t Veer, Daphne de Jong	197
19	Mechanisms and Effects of Loss of Human Leukocyte Antigen Class II Expression in Immune-Privileged Site-Associated B-Cell Lymphoma 2006 ·Clinical Cancer Research ·Marije Booman, (unknown), Annuska M. Glas, Sietske A. Riemersma, Ekaterina S. Jordanova, Klaas Kok, Andreas Rosenwald, Daphne de Jong, Ed Schuuring, Philip M. Kluin	53
20	High Response Rates and Lasting Remissions After Low-Dose Involved Field Radiotherapy in Indolent Lymphomas 2003 ·Journal of Clinical Oncology ·Rick L. Haas, P Poortmans, Daphne de Jong, Berthe M.P. Aleman, L. Dewit, Marcel Verheij, A.A.M. Hart, Marinus H. J. van Oers, M. van der Hulst, (unknown), Harry Bartelink	119

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact